MangoRx vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats MangoRx overall, scoring 7.7/10 vs 7.5/10. Choose MangoRx for users who want a multi-service telehealth platform covering . Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of MangoRx and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
MangoRx
#23 of 40Multi-service telehealth platform offering compounded GLP-1 alongside other health services.
Visit MangoRxMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | MangoRx | MEDVi |
|---|---|---|
| Our Score | 7.5/10 | 7.7/10 |
| Starting Price | $299/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a multi-service telehealth platform covering weight loss and men's health | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #23 | #21 |
Pros & Cons Compared
MangoRx
Pros
- +Oral dissolving tablets exclusively — zero injections for any GLP-1 option
- +Publicly traded on NASDAQ (MGRX) — SEC-required financial transparency that private competitors can't match
- +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
- +Free 100% online consultation with no video call required
Cons
- −$299/mo for oral semaglutide is 2-3x the cost of injectable alternatives at $99-149/mo
- −Early-stage public company with limited revenue — stock performance reflects financial uncertainty
- −Only oral tablet format available — no injectable options if you want higher bioavailability
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out MangoRx with a score of 7.7/10 vs 7.5/10. Choose MangoRx if you want: users who want a multi-service telehealth platform covering weight loss and men's health. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.